Calliditas TherapeuticsCALT

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Ms. Renee Aguiar-Lucander

$571.8M

Market Cap • 23/05/2024

2004

(há 20 anos)
Fundação

2020

(4 years ago)
IPO

NASDAQ

Listagem
Flag of SE

Stockholm

102

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CALTSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

3%

1 dia

20/05/2024

3%

1 semana

16/05/2024

25%

1 mês

23/04/2024

18%

1 ano

23/05/2023

10 anos

Histórico